Biotechnology Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Biotechnology
Cyclacel Pharmaceuticals Inc (CYCC) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Waters and Advancing Clinical Trials
Insights into CYCC's financial health and strategic advancements in oncology research during the first quarter of 2024. 4 hours ago
GuruFocus Research Biotechnology
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Advances Amid Challenges
Explore key financial outcomes, product launches, and strategic initiatives as Arcutis Biotherapeutics navigates through a dynamic market landscape. 5 hours ago
GuruFocus Research Biotechnology
TRACON Pharmaceuticals Inc (TCON) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid Financial Challenges
Explore key insights from TRACON Pharmaceuticals' Q1 2024 earnings, focusing on financial improvements, trial progress, and strategic maneuvers to maintain NASDAQ compliance. 5 hours ago
GuruFocus Research Biotechnology
scPharmaceuticals Inc (SCPH) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and Expanding Opportunities
Despite a net loss and increased operational costs, scPharmaceuticals Inc (SCPH) reports significant progress in product development and market expansion. 6 hours ago
GuruFocus Research Biotechnology
BioStem Technologies Inc (BSEM) Q1 2024 Earnings Call Transcript Highlights: A Remarkable Turnaround with Record Revenues and Profits
Discover how BioStem Technologies achieved a significant revenue increase and reported its first positive net income in Q1 2024. 6 hours ago
GuruFocus Research Biotechnology
MiNK Therapeutics Inc (INKT) Q1 2024 Earnings Call Transcript Highlights: Strategic Reductions and Promising Investments
Discover how MiNK Therapeutics Inc navigates financial challenges and advances key clinical programs amidst strategic operational adjustments. 6 hours ago
GuruFocus Research Biotechnology
Syros Pharmaceuticals Inc (SYRS) (Q1 2024) Earnings Call Transcript Highlights: Strategic Developments and Financial Insights
Explore key updates on clinical trials, financial shifts, and strategic insights from Syros Pharmaceuticals' Q1 2024 earnings call. 6 hours ago